Devoted Health 2024 financials reveal revenue growthnews2025-04-29T13:00:16+00:00April 29th, 2025|Endpoints News|
Octagon Therapeutics shuts down after ‘unresolved biology questions’news2025-04-29T06:08:21+00:00April 29th, 2025|Endpoints News|
Versant’s latest biotech focuses on inflammatory diseasesnews2025-04-24T12:00:31+00:00April 24th, 2025|Endpoints News|
Genentech vet launches ADC startup with $20Mnews2025-04-23T11:30:11+00:00April 23rd, 2025|Endpoints News|
Repertoire inks autoimmune deal with Genentech as it eyes a return to the clinicnews2025-04-23T11:00:32+00:00April 23rd, 2025|Endpoints News|
Exclusive: Chicago startup Grove Biopharma nabs $30M Series Anews2025-04-23T11:00:18+00:00April 23rd, 2025|Endpoints News|
George Church startup Matter Bio will study long-lived animals, humansnews2025-04-22T14:35:00+00:00April 22nd, 2025|Endpoints News|
China biotech startup HuidaGene uses CRISPR in brain for rare ailmentnews2025-04-21T15:00:57+00:00April 21st, 2025|Endpoints News|
China-based VelaVigo inks its second US biotech dealnews2025-04-17T19:00:02+00:00April 17th, 2025|Endpoints News|
Early funding for biotechs slumps further in 2025 after several rough yearsnews2025-04-16T14:00:03+00:00April 16th, 2025|Endpoints News|
